Is your biochemical assay not sensitive enough to characterize inhibitors with affinities of hundreds of µM? Does your assay suffer from false readout from the intrinsic fluorescence of compounds at high concentration? Did you know that Surface Plasmon Resonance (SPR) can be set up in such a way that the readout represents the biologically relevant interaction of two biological partners, and therefore it can directly detect compounds disrupting such interactions?
Webinar: “Epitranscriptomics and Disease: The Role of RNA Modification in the Life Cycle of the Cell.”
Online Targeting both RNA and the proteins that interact with it has become one of the hottest new areas in drug discovery. Biotechs such as Storm Therapeutics, 28-7, Gotham Therapeutics and Accent Therapeutics amongst many others, are all developing small molecule inhibitors of misregulated epigenetic processes. On Wednesday, June 30th ZoBio organized together with Cambridge…
Drug Discovery Chemistry Virtual
Online ZoBio contributes since the start of Cambridge Healthtech Institute’s (CHI) Drug Discovery Chemistry to this dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists. On Tuesday 18 May Stijn Gremmen, Head of Chemistry at ZoBio…
We Have No Open Positions at This Time
However, if you want to be added to our talent pool, send your CV, motivation letter and names of potential referees at hrm@zobio.com You will be notified in case that we have a job opening for which you would be a good match.